Nav: Home

In-hospital nocturnal dialysis may be good for the heart

September 18, 2015

TORONTO, Sept. 18, 2015--In-hospital nocturnal dialysis may be good for patients' hearts as well as their kidneys, a new study suggests.

People with end-stage kidney disease who receive chronic dialysis have high rates of cardiovascular disease and death from cardiovascular disease. About 15-20 per cent of dialysis patients die each year, most from cardiovascular disease.

Interventions that reduce the risk of cardiovascular disease in the general population have less success with dialysis patients, suggesting there may be unique mechanisms driving cardiovascular disease in patients with advanced kidney disease. The dialysis procedure itself, especially when performed on a conventional schedule of 12 hours a week, may promote or exacerbate cardiovascular disease.

Little is known about the link between in-hospital nocturnal dialysis, one of the most intense forms dialysis, and cardiovascular disease. In a study published today in the Canadian Journal of Cardiology, a team led by Drs. Ron Wald and Andrew Yan of St. Michael's Hospital compared the thickness of the heart wall in patients who converted to in-hospital nocturnal dialysis and those who remained on conventional dialysis.

They found that compared with conventional dialysis, in-hospital nocturnal dialysis was associated with a "significant reduction" in left ventricular mass after one year. The left ventricle is the bottom left chamber of the heart, which pumps blood out to the aorta and to the rest of the body. The size or mass of the left ventricle is an important risk factor in cardiovascular disease, with a larger mass being associated with more cardiovascular disease and more deaths from cardiovascular disease. Importantly, reduction in left ventricular mass has also been linked to a lower risk of cardiovascular diseases such as heart failure, heart attack and stroke.

The study also found a trend toward lower blood pressure among in-hospital nocturnal dialysis patients compared to the conventional dialysis patients and lower blood phosphate levels, another marker of adverse cardiovascular outcomes.

Patients receiving conventional dialysis get 12 hours of dialysis a week, given as four hours a session, three days per week. In-hospital nocturnal dialysis provides twice as much time - eight hours on each of three nights.

"This study is good news in several ways," said Dr. Wald, a nephrologist. "It suggests there is a cardiovascular benefit for people who are receiving in-hospital nocturnal dialysis and it may encourage other kidney patients to switch to this more intense form of dialysis. In addition to the potential health benefits, nighttime dialysis may free up patients' daytime hours to do the things that hemodialysis treatments typically disrupt such as employment, child care and household chores."

Dr. Yan, a cardiologist, noted this study was not a randomized clinical trial, so the conclusions that can be drawn are that in-hospital nocturnal dialysis is associated with reduced left ventricular mass, not that it necessarily caused the reduction. Nevertheless, their findings are consistent with other randomized trials of intensified dialysis, and provide support for the use of in-hospital nocturnal dialysis among eligible patients.
This study was funded by the Canadian Institutes of Health Research.

About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in more than 23 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, and care of the homeless are among the Hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Centre, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

Media contacts

For more information, or to arrange an interview, contact:
Leslie Shepherd
Manager, Media Strategy
St. Michael's Hospital
Inspired Care. Inspiring Science.
Follow us on Twitter:

St. Michael's Hospital

Related Cardiovascular Disease Articles:

Is educational attainment associated with lifetime risk of cardiovascular disease?
Men and women with the lowest education level had higher lifetime risks of cardiovascular disease than those with the highest education level, according to a new study published by JAMA Internal Medicine.
Food policies could lower US cardiovascular disease rates
New research conducted by the University of Liverpool and partners shows that food policies, such as fruit and vegetable subsidies, taxes on sugar sweetened drinks, and mass media campaigns to change dietary habits, could avert hundreds of thousands of deaths from cardiovascular disease (CVD) in the United States.
Cardiovascular disease causes one-third of deaths worldwide
Cardiovascular diseases (CVD), including heart diseases and stroke, account for one-third of deaths throughout the world, according to a new scientific study that examined every country over the past 25 years.
Kidney disease is a major cause of cardiovascular deaths
In 2013, reduced kidney function was associated with 4 percent of deaths worldwide, or 2.2 million deaths.
Cardiovascular disease costs will exceed $1 trillion by 2035
A new study projects that by 2035, cardiovascular disease, the most costly and prevalent killer, if left unchecked, will place a crushing economic and health burden on the nation's financial and health care systems.
Prescribing drugs for cardiovascular disease prevention in the UK
Drugs such as statins that have the potential to prevent strokes and other types of cardiovascular disease have not been prescribed to a large proportion of people at risk in the UK, according to a research article by Grace Turner of the University of Birmingham, Birmingham, UK and colleagues published in PLOS Medicine.
Fatty liver disease contributes to cardiovascular disease and vice versa
For the first time, researchers have shown that a bi-directional relationship exists between fatty liver disease and cardiovascular disease.
More dietary calcium may lower risk of cardiovascular disease
In older people, higher dietary calcium intake may lower the risk of cardiovascular disease, but not of stroke and fracture, new research from South Korea suggests.
Renal hemodynamics and cardiovascular function in health and disease
The SRC will focus on unpublished work that is state-of-the-art in study of cardiovascular and renal disease and hypertension.
Cardiovascular disease in adult survivors of childhood cancer
For adult survivors of childhood cancer, cardiovascular disease presents at an earlier age, is associated with substantial morbidity, and is often asymptomatic.

Related Cardiovascular Disease Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.